The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases
Case Report
[키워드] activate
Activation
acute phase
acute respiratory syndrome
addition
Adhesion Molecule
administration
adopted
alteration
anti-inflammatory properties
Anticoagulant
anticoagulant therapy
Anticoagulants
blood chemistry
cardiovascular risk
Cell
characterized
circulating
clinical
clinical expression
Coagulation
coagulation cascade
Coagulation factors
coagulation parameter
Coagulopathy
complicate
component
Coronavirus-2
COVID-19
COVID-19 patient
COVID-19 patients
criteria
cross-talk
cytokine
cytokine expression
Cytokines
death rate
Disseminated intravascular coagulation
DOAC
DOACs
Efficacy
endothelial damage
evaluate
factor Xa
Growth factors
IMPROVE
Inflammation
Inflammatory
inhibit
leucocyte
LMWH
Local
long-COVID-19
oral anticoagulant
outcomes
PARs
Patient
patients
persistence
PF4
Platelet
promote inflammation
prothrombotic state
receptor
SARS-CoV-2
storm
suggested
Survivors
Symptom
syndrome
target
thrombin
Treatment
Venous Thromboembolism
VTE
[DOI] 10.3390/v13101904 PMC 바로가기 [Article Type] Case Report
[DOI] 10.3390/v13101904 PMC 바로가기 [Article Type] Case Report